Literature DB >> 19459027

Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.

Atsunori Ishimura1, Maho Watanabe1, Hitoshi Nakashima2, Kenji Ito1, Katsuhisa Miyake1, Shizue Mochizuki3, Yasushi Ishigaki4, Takao Saito1.   

Abstract

OBJECTIVE: A mutant of apolipoproteinE (apoE), ApoE-Sendai (Arg145Pro), is one of the major causative factors of human lipoprotein glomerulopathy (LPG). An apoE-deficient mouse with introduced ApoE-Sendai gene (ApoE-Sendai mouse) developed a murine counterpart of LPG, whereas it was also reported that apoE-deficient mouse (apoE KO mouse) spontaneously developed LPG-like lesion regardless of introduction of ApoE-Sendai gene. In the present study, we differentiated renal lesions between these two models by detailed analyses of histology and lipoprotein profile, and clarified the role of apoE variants.
METHOD: ApoE-Sendai mice were induced by injection of adenovirus vectors. The kidneys showing LPG-like lesions in apoE-Sendai and apoE KO mice were histopathologically evaluated. Plasma lipids and lipoproteins of both mice were also examined.
RESULTS: Histological alteration of the kidney in ApoE-Sendai mice was observed with light microscopy (in 40 out of 50 mice; mild 24, moderate 13, severe 3). Characteristic lesions were dilated vascular lumens mimicking lipoprotein thrombi in human LPG. Similar changes were found in hematoxylin-eosin stained sections of aged apoE KO mice. Meanwhile, periodic acid-Schiff, Azan Mallory, and Oil red O/Sudan III stained sections revealed that the dilated lumens of ApoE-Sendai mice mainly contained lipids and lipoproteins but those of aged apoE KO mice contained much other materials, e.g., proteins and fibrils. These findings were supported by electron micrographs, in which round-shaped droplets indicating lipoproteins were observed in ApoE-Sendai mice but not in aged apoE KO mice. In the kidney of apoE KO mice many anti-mouse CD68 Ab positive cells were detected. This contrasts with the result seen in ApoE-Sendai mice. The plasma lipoprotein compositions of the two types of mice were totally different.
CONCLUSION: It was certain that the kidneys of aged apoE KO mice showed morphological alteration, but the histological findings of glomerular lesions were different from those seen in the kidneys of ApoE-Sendai mice. According to the histological findings and plasma lipoprotein profile, ApoE-Sendai mice, not apoE KO mice, is a murine model for human LPG. This means that apoE variants are essential to LPG.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19459027     DOI: 10.1007/s10157-009-0195-1

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  28 in total

Review 1.  Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.

Authors:  Takao Saito; Akira Matsunaga; Shinichi Oikawa
Journal:  Am J Kidney Dis       Date:  2006-02       Impact factor: 8.860

Review 2.  Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

Authors:  H Vlassara; R Bucala; L Striker
Journal:  Lab Invest       Date:  1994-02       Impact factor: 5.662

3.  A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.

Authors:  A Matsunaga; J Sasaki; T Komatsu; K Kanatsu; E Tsuji; K Moriyama; T Koga; K Arakawa; S Oikawa; T Saito; T Kita; T Doi
Journal:  Kidney Int       Date:  1999-08       Impact factor: 10.612

4.  Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney.

Authors:  T Miyata; S Sugiyama; M Nangaku; D Suzuki; K Uragami; R Inagi; H Sakai; K Kurokawa
Journal:  J Am Soc Nephrol       Date:  1999-07       Impact factor: 10.121

5.  The glomerulosclerosis of aging in females: contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration.

Authors:  Feng Zheng; Qing-Li Cheng; Anna-Rita Plati; Shui Qin Ye; Mariana Berho; Anita Banerjee; Mylene Potier; Edgar A Jaimes; Hong Yu; You-Fei Guan; Chung-Ming Hao; Liliane J Striker; Gary E Striker
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

6.  Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor.

Authors:  C Baylis
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy.

Authors:  S Oikawa; N Suzuki; E Sakuma; T Saito; K Namai; H Kotake; Y Fujii; T Toyota
Journal:  Am J Kidney Dis       Date:  1991-11       Impact factor: 8.860

Review 8.  Focal and segmental glomerulosclerosis: analogies to atherosclerosis.

Authors:  J R Diamond; M J Karnovsky
Journal:  Kidney Int       Date:  1988-05       Impact factor: 10.612

Review 9.  Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.

Authors:  P de Knijff; A M van den Maagdenberg; R R Frants; L M Havekes
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

10.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

Authors:  S H Zhang; R L Reddick; J A Piedrahita; N Maeda
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

View more
  9 in total

Review 1.  Glomerular diseases: genetic causes and future therapeutics.

Authors:  Chih-Kang Chiang; Reiko Inagi
Journal:  Nat Rev Nephrol       Date:  2010-07-20       Impact factor: 28.314

2.  Five-year follow-up of a case of lipoprotein glomerulopathy with APOE Kyoto mutation.

Authors:  Ryosuke Usui; Masaki Takahashi; Kosaku Nitta; Minako Koike
Journal:  CEN Case Rep       Date:  2016-03-04

3.  Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice.

Authors:  Hagai Tavori; Daping Fan; Ilaria Giunzioni; Lin Zhu; MacRae F Linton; Agnes B Fogo; Sergio Fazio
Journal:  J Lipid Res       Date:  2014-09-02       Impact factor: 5.922

Review 4.  Systemic and renal lipids in kidney disease development and progression.

Authors:  Patricia Wahl; Gloria Michelle Ducasa; Alessia Fornoni
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-23

Review 5.  Topics in lipoprotein glomerulopathy: an overview.

Authors:  Takao Saito; Akira Matsunaga; Kenji Ito; Hitoshi Nakashima
Journal:  Clin Exp Nephrol       Date:  2013-10-23       Impact factor: 2.801

6.  Atherosclerosis, inflammation and lipoprotein glomerulopathy in kidneys of apoE-/-/LDL-/- double knockout mice.

Authors:  Alexander C Langheinrich; Marian Kampschulte; Franziska Scheiter; Christian Dierkes; Philip Stieger; Rainer M Bohle; Wolfgang Weidner
Journal:  BMC Nephrol       Date:  2010-08-20       Impact factor: 2.388

7.  Genetic analysis of intracapillary glomerular lipoprotein deposits in aging mice.

Authors:  Gerda A Noordmans; Yuan Huang; Holly Savage; Marcory C R F van Dijk; Gert Schaart; Marius A van den Bergh Weerman; Peter Heeringa; Jan-Luuk Hillebrands; Ron Korstanje; Harry van Goor
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

Review 8.  Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.

Authors:  Sandra Merscher; Christopher E Pedigo; Armando J Mendez
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-14       Impact factor: 5.555

Review 9.  Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: A review.

Authors:  Eduardo Cambruzzi; Karla Lais Pêgas
Journal:  J Bras Nefrol       Date:  2018-11-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.